Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13717
Country/Region: Uganda
Year: 2015
Main Partner: Uganda Episcopal Conference
Main Partner Program: Registered Trustees
Organizational Type: Implementing Agency
Funding Agency: HHS/CDC
Total Funding: $6,635,263 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,810,176
Care: Orphans and Vulnerable Children (HKID) $157,506
Care: TB/HIV (HVTB) $341,821
Care: Pediatric Care and Support (PDCS) $410,631
Laboratory Infrastructure (HLAB) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $279,275
Sexual Prevention: Abstinence/Be Faithful (HVAB) $50,606
Testing: HIV Testing and Counseling (HVCT) $266,882
Sexual Prevention: Other Sexual Prevention (HVOP) $82,900
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $232,935
Treatment: Adult Treatment (HTXS) $2,828,633
Treatment: Pediatric Treatment (PDTX) $173,898
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 22,433
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 2,279
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 43,797
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 2,707
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 71,216
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 71,216
CARE_NEW Aggregated Age/sex: <15 Female 2016 233
CARE_NEW Aggregated Age/sex: <15 Male 2016 206
CARE_NEW Aggregated Age/sex: 15+ Female 2016 4,018
CARE_NEW Aggregated Age/sex: 15+ Male 2016 2,186
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 6,643
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 6,643
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 6,643
FN_THER Aggregated Age: <18 2016 658
FN_THER Aggregated Age: 18+ 2016 1,051
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 1,709
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 21,365
FN_THER Sum of Aggregated Age disaggregates 2016 1,709
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 11,031
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 8,320
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 84,184
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 60,674
HTS_TST By Test Result: Negative 2016 158,263
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 164,209
HTS_TST Sum of Aggregated Age/Sex <15 2016 19,351
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 144,858
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 164,209
HTS_TST Sum of Test Result disaggregates 2016 164,209
HTS_TST_POS By Test Result: Positive 2016 5,946
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2016 1
LAB_CAP By clinical laboratories 2016 18
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 18
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2016 2,230
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2016 4,339
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 3,542
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 3,542
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 2,868
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 674
PMTCT_ARV Sum of New and Current disaggregates 2016 3,542
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 282
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 2,834
PMTCT_EID Sum of Infant Age disaggregates 2016 2,834
PMTCT_STAT By: Known positives at entry 2016 2,868
PMTCT_STAT By: Number of new positives identified 2016 674
PMTCT_STAT Number of new ANC and L&D clients 2016 34,057
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 32,354
PMTCT_STAT Sum of Positives Status disaggregates 2016 3,542
PP_PREV Age/sex: 10-14 Female 2016 4,329
PP_PREV Age/sex: 10-14 Female 2016 3,991
PP_PREV Age/sex: 10-14 Male 2016 3,350
PP_PREV Age/sex: 10-14 Male 2016 2,609
PP_PREV Age/sex: 15-19 Female 2016 8,712
PP_PREV Age/sex: 15-19 Female 2016 4,307
PP_PREV Age/sex: 15-19 Male 2016 7,002
PP_PREV Age/sex: 15-19 Male 2016 3,150
PP_PREV Age/sex: 20-24 Female 2016 12,863
PP_PREV Age/sex: 20-24 Male 2016 8,022
PP_PREV Age/sex: 25-49 Female 2016 18,506
PP_PREV Age/sex: 25-49 Male 2016 13,466
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 78,585
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 14,057
PP_PREV Sum of Age/Sex disaggregates 2016 78,585
PP_PREV Sum of Age/Sex disaggregates 2016 14,057
TB_ART Aggregated Age: <15 2016 65
TB_ART Aggregated Age: 15+ 2016 876
TB_ART Female 2016 607
TB_ART Male 2016 334
TB_ART Sum of Aggregated Age disaggregates 2016 941
TB_ART Sum of Sex disaggregates 2016 941
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 1,177
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 941
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 4,983
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 66,233
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 71,216
TB_SCREEN Sex: Female 2016 46,504
TB_SCREEN Sex: Male 2016 24,712
TB_SCREEN Sum of Aggregated Age disaggregates 2016 71,216
TB_SCREEN Sum of Sex disaggregates 2016 71,216
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 71,216
TX_CURR Aggregated Age/Sex: 15+ Female 2016 19,425
TX_CURR Aggregated Age/Sex: 15+ Male 2016 42,210
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 66,530
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 61,635
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 61,635
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 4,050
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 8,549
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 13,149
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 12,599
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 8,481
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 9,977
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2016 27
VMMC_CIRC By circumcision technique: Surgical VMMC 2016 8,001
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 8,001
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 7,857
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2016 144
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 8,001
Cross Cutting Budget Categories and Known Amounts Total: $1,520,000
Renovation $70,000
Gender: Gender Based Violence (GBV) $700,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Gender: Gender Equality $350,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Key Populations: Sex Workers $400,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention